October 19, 2018
Rose
With the purchase, the Swiss company is adding to its arsenal of radiopharmaceuticals, a new group of drugs designed to more closely target cancer cells.
from Kaiser Health News https://ift.tt/2CRTjMh
October 19, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Dementia And Guns: When Should Doctors Broach The Topic?- Fact-Check: Who’s Right On Protections For Preexisting Conditions? It’s Complicated
- First Edition: October 12, 2018
- Obamacare Premiums Dip For First Time. Some Call It A Correction
- Podcast: KHN’s ‘What The Health?’ Falling Premiums And Rising Political Tensions
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment